Literature DB >> 8104338

Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1.

J E Sligh1, C M Ballantyne, S S Rich, H K Hawkins, C W Smith, A Bradley, A L Beaudet.   

Abstract

Gene targeting was used to produce mice deficient in intercellular adhesion molecule 1 (ICAM-1) or CD54, an immunoglobulin-like cell adhesion molecule that binds beta 2 integrins. Homozygous deficient animals develop normally, are fertile, and have a moderate granulocytosis. The nature of the mutation, RNA analysis, and immunostaining are consistent with complete loss of surface expression of ICAM-1. Deficient mice exhibit prominent abnormalities of inflammatory responses including impaired neutrophil emigration in response to chemical peritonitis and decreased contact hypersensitivity to 2,4-dinitrofluorobenzene. Mutant cells provided negligible stimulation in the mixed lymphocyte reaction, although they proliferated normally as responder cells. These mutant animals will be extremely valuable for examining the role of ICAM-1 and its counterreceptors in inflammatory disease processes and atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8104338      PMCID: PMC47390          DOI: 10.1073/pnas.90.18.8529

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Inhibition of mixed lymphocyte response by a rat monoclonal antibody to a novel murine lymphocyte activation antigen (MALA-2).

Authors:  F Takei
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

2.  Monoclonal antibodies to leukocyte integrins CD11a/CD18 and CD11b/CD18 or intercellular adhesion molecule-1 inhibit chemoattractant-stimulated neutrophil transendothelial migration in vitro.

Authors:  M B Furie; M C Tancinco; C W Smith
Journal:  Blood       Date:  1991-10-15       Impact factor: 22.113

3.  Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation.

Authors:  M S Diamond; D E Staunton; S D Marlin; T A Springer
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

4.  Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T lymphocytes.

Authors:  N K Damle; K Klussman; P S Linsley; A Aruffo
Journal:  J Immunol       Date:  1992-04-01       Impact factor: 5.422

5.  Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1.

Authors:  M Isobe; H Yagita; K Okumura; A Ihara
Journal:  Science       Date:  1992-02-28       Impact factor: 47.728

6.  An initiation codon mutation in CD18 in association with the moderate phenotype of leukocyte adhesion deficiency.

Authors:  J E Sligh; M Y Hurwitz; C M Zhu; D C Anderson; A L Beaudet
Journal:  J Biol Chem       Date:  1992-01-15       Impact factor: 5.157

7.  In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts.

Authors:  A B Cosimi; D Conti; F L Delmonico; F I Preffer; S L Wee; R Rothlein; R Faanes; R B Colvin
Journal:  J Immunol       Date:  1990-06-15       Impact factor: 5.422

8.  The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells.

Authors:  G A Van Seventer; Y Shimizu; K J Horgan; S Shaw
Journal:  J Immunol       Date:  1990-06-15       Impact factor: 5.422

9.  Co-stimulation of T cell proliferation by transforming growth factor-beta 1.

Authors:  H M Lee; S Rich
Journal:  J Immunol       Date:  1991-08-15       Impact factor: 5.422

10.  Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytes.

Authors:  A R de Fougerolles; T A Springer
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

View more
  121 in total

1.  Assessing vascular permeability during experimental cerebral malaria by a radiolabeled monoclonal antibody technique.

Authors:  H C van der Heyde; P Bauer; G Sun; W L Chang; L Yin; J Fuseler; D N Granger
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  Mononuclear cell recruitment, granuloma assembly, and response to treatment in experimental visceral leishmaniasis: intracellular adhesion molecule 1-dependent and -independent regulation.

Authors:  H W Murray
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

Review 3.  Innate immunity and inflammation: a transcriptional paradigm.

Authors:  J Hawiger
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 4.  Pathways and bottlenecks in the web of inflammatory adhesion molecules and chemoattractants.

Authors:  K Ley
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 5.  Adhesion molecule cascades direct lymphocyte recirculation and leukocyte migration during inflammation.

Authors:  D A Steeber; T F Tedder
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

6.  CD18 and ICAM-1-dependent corneal neovascularization and inflammation after limbal injury.

Authors:  Y Moromizato; S Stechschulte; K Miyamoto; T Murata; A Tsujikawa; A M Joussen; A P Adamis
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

7.  Cerebral leucocyte infiltration in lupus-prone MRL/MpJ-fas lpr mice--roles of intercellular adhesion molecule-1 and P-selectin.

Authors:  W G James; P Hutchinson; D C Bullard; M J Hickey
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

8.  Vascular adhesion protein-1 is involved in both acute and chronic inflammation in the mouse.

Authors:  Marika Merinen; Heikki Irjala; Marko Salmi; Ilkka Jaakkola; Arno Hänninen; Sirpa Jalkanen
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

9.  ICAM-1null C57BL/6 Mice Are Not Protected from Experimental Ischemic Stroke.

Authors:  Gaby U Enzmann; Sofia Pavlidou; Markus Vaas; Jan Klohs; Britta Engelhardt
Journal:  Transl Stroke Res       Date:  2018-02-04       Impact factor: 6.829

10.  Expression of a single ICAM-1 isoform on T cells is sufficient for development of experimental autoimmune encephalomyelitis.

Authors:  Daniel C Bullard; Xianzhen Hu; David Crawford; Kristin McDonald; Theresa N Ramos; Scott R Barnum
Journal:  Eur J Immunol       Date:  2014-02-11       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.